Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Gartlon JE"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ellard JM; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Madin A; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Philps O; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Hopkin M; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Henderson S; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Birch L; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., O'Connor D; DMPK, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Arai T; Next Generation Systems Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd, 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635 Japan., Takase K; Biomarker and Personalized Medicine Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd, 5-1-3 Tokodai, Tsukuba, Ibaraki 300-2635 Japan., Morgan L; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Reynolds D; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Talma S; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Howley E; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Powney B; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Payne AH; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Hall A; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Gartlon JE; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Dawson LA; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Castro L; Medicinal Chemistry, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK., Atkinson PJ; Pharmacology, Neuroscience Product Creation Unit, Eisai Limited, European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, UK. Electronic address: Peter_Atkinson@eisai.net.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 Dec 15; Vol. 25 (24), pp. 5792-6. Date of Electronic Publication: 2015 Oct 17.
Autor:
Johnson DJ; GlaxoSmithKline, New Frontiers Science Park, 3rd Avenue, Harlow, Essex CM19 5AW, UK. dalejames.johnson@gmail.com, Forbes IT, Watson SP, Garzya V, Stevenson GI, Walker GR, Mudhar HS, Flynn ST, Wyman PA, Smith PW, Murkitt GS, Lucas AJ, Mookherjee CR, Watson JM, Gartlon JE, Bradford AM, Brown F
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2010 Sep 15; Vol. 20 (18), pp. 5434-8. Date of Electronic Publication: 2010 Jul 30.
Autor:
Cilia J; Department of Biology, New Frontiers Science Park, GlaxoSmithKline plc, Harlow, Essex, UK., Gartlon JE, Shilliam C, Dawson LA, Moore SH, Jones DN
Publikováno v:
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2010 Mar; Vol. 24 (3), pp. 407-19. Date of Electronic Publication: 2009 Feb 09.
Autor:
Woolley ML; Neurosciences CEDD, GlaxoSmithKline plc, New Frontiers Science Park, Harlow, Essex, England. marie.2.woolley-roberts@gsk.com, Carter HJ, Gartlon JE, Watson JM, Dawson LA
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2009 Jan 28; Vol. 603 (1-3), pp. 147-9. Date of Electronic Publication: 2008 Dec 16.
Autor:
Southam E; GlaxoSmithKline, New Frontiers Science Park (North), Third Avenue, Harlow, Essex, CM195AW, UK. eric_2_southam@gsk.com, Cilia J, Gartlon JE, Woolley ML, Lacroix LP, Jennings CA, Cluderay JE, Reavill C, Rourke C, Wilson DM, Dawson LA, Medhurst AD, Jones DN
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2009 Jan; Vol. 201 (4), pp. 483-94. Date of Electronic Publication: 2008 Sep 03.
Autor:
Woolley ML; Neurosciences Centre of Excellence for Drug Discovery, GlaxoSmithKline plc, New Frontiers Science Park, Third Avenue, Harlow, Essex CM195AW, UK. marie.2.woolley-roberts@gsk.com, Waters KA, Gartlon JE, Lacroix LP, Jennings C, Shaughnessy F, Ong A, Pemberton DJ, Harries MH, Southam E, Jones DN, Dawson LA
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2009 Jan; Vol. 202 (1-3), pp. 343-54. Date of Electronic Publication: 2008 Sep 16.
Publikováno v:
Schizophrenia research [Schizophr Res] 2007 Aug; Vol. 94 (1-3), pp. 371-2. Date of Electronic Publication: 2007 Jun 08.